Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

November 01, 1985; Volume 13,Issue 6
  • You have access
    In vitro digitoxin metabolism. Rate-limiting step and alteration following spironolactone pretreatment.
    W C Kershaw, P Campbell and G L Lage
    Drug Metabolism and Disposition November 1985, 13 (6) 635-639;
  • You have access
    Paraoxon hydrolysis vs. covalent binding in the elimination of paraoxon in the rabbit.
    E G Butler, H W Eckerson and B N La Du
    Drug Metabolism and Disposition November 1985, 13 (6) 640-645;
  • You have access
    Tissue uptake and metabolism of amiodarone after chronic administration in rabbits.
    R Kannan, S Miller and B N Singh
    Drug Metabolism and Disposition November 1985, 13 (6) 646-650;
  • You have access
    Isomer- and sex-specific bioactivation of mononitrotoluenes. Role of enterohepatic circulation.
    J P Chism and D E Rickert
    Drug Metabolism and Disposition November 1985, 13 (6) 651-657;
  • You have access
    In vitro characteristics of guinea pig lung aromatic azaheterocycle N-methyltransferase.
    K C Cundy and P A Crooks
    Drug Metabolism and Disposition November 1985, 13 (6) 658-663;
  • You have access
    Metabolism of dinitrobenzenes by rat isolated hepatocytes.
    P A Cossum and D E Rickert
    Drug Metabolism and Disposition November 1985, 13 (6) 664-668;
  • You have access
    S-Methylation of D- and L-penicillamine by human erythrocyte membrane thiol methyltransferase.
    R A Keith, D M Otterness, A L Kerremans and R M Weinshilboum
    Drug Metabolism and Disposition November 1985, 13 (6) 669-676;
  • You have access
    Pharmacokinetic and metabolism studies of two novel 1-deaza-7,8-dihydropteridines in mice.
    P E Noker, D L Hill, J R Kalin, C G Temple and J A Montgomery
    Drug Metabolism and Disposition November 1985, 13 (6) 677-681;
  • You have access
    In vivo mammalian metabolism of methylamine and methylurea and their metabolic interrelationship.
    M S Dar and E R Bowman
    Drug Metabolism and Disposition November 1985, 13 (6) 682-689;
  • You have access
    Structure of the glutathione adduct of activated 3-methylindole indicates that an imine methide is the electrophilic intermediate.
    M R Nocerini, G S Yost, J R Carlson, D J Liberato and R G Breeze
    Drug Metabolism and Disposition November 1985, 13 (6) 690-694;
  • You have access
    Effects of taurocholate infusion on biliary excretion in isolated perfused rat livers. Decreased biliary excretion of dibromosulfophthalein in pregnancy.
    S Durham, R Mack and M Vore
    Drug Metabolism and Disposition November 1985, 13 (6) 695-699;
  • You have access
    Separation, purification, and characterization of digitoxigenin-monodigitoxoside UDP-glucuronosyltransferase activity.
    L von Meyerinck, B L Coffman, M D Green, R B Kirkpatrick, A Schmoldt and T R Tephly
    Drug Metabolism and Disposition November 1985, 13 (6) 700-704;
  • You have access
    Furosemide 1-O-acyl glucuronide. In vitro biosynthesis and pH-dependent isomerization to beta-glucuronidase-resistant forms.
    A Rachmel, G A Hazelton, A L Yergey and D J Liberato
    Drug Metabolism and Disposition November 1985, 13 (6) 705-710;
  • You have access
    Age-related changes in the activities of epoxide hydrolases in different tissues of mice.
    S Kaur and S S Gill
    Drug Metabolism and Disposition November 1985, 13 (6) 711-715;
  • You have access
    Metabolism of strychnine in vitro.
    M Mishima, Y Tanimoto, Z Oguri and H Yoshimura
    Drug Metabolism and Disposition November 1985, 13 (6) 716-721;
  • You have access
    7-Ethoxycoumarin O-deethylation and methylumbelliferone conjugation in isolated fetal and adult bovine hepatocytes.
    E M Soulinna and A M Winberg
    Drug Metabolism and Disposition November 1985, 13 (6) 722-724;
  • You have access
    Comparison of theophylline and theobromine metabolism in man.
    D J Birkett, R Dahlqvist, J O Miners, A Lelo and B Billing
    Drug Metabolism and Disposition November 1985, 13 (6) 725-728;
  • You have access
    Physiologically based pharmacokinetic model for cefazolin in rabbits and its preliminary extrapolation to man.
    A Tsuji, K Nishide, H Minami, E Nakashima, T Terasaki and T Yamana
    Drug Metabolism and Disposition November 1985, 13 (6) 729-739;
  • You have access
    Quantitation of extrahepatic metabolism. Pulmonary and intestinal conjugation of naphthol.
    M Mistry and J B Houston
    Drug Metabolism and Disposition November 1985, 13 (6) 740-745;
  • You have access
    Mephenytoin hydroxylase activity in human liver: inhibition by steroids.
    M Jurima, T Inaba and W Kalow
    Drug Metabolism and Disposition November 1985, 13 (6) 746-749;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 13, Issue 6
1 Nov 1985
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics